Published in Obesity and Diabetes Week, October 2nd, 2006
This is the largest analysis conducted to assess heart disease patients who have metabolic syndrome and have taken statins.
According to this secondary analysis, patients with heart disease and metabolic syndrome who took the Lipitor 80mg dose reduced their risk of major cardiovascular events such as heart attacks by nearly 30% compared with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.